RZ

Roger Zhang

Senior Associate at Samsara BioCapital

San Francisco, California

Overview 

Roger Zhang is a Senior Associate at Samsara BioCapital in San Francisco, California, with a background in pharmacology and drug discovery. He has held leadership roles at various biotech companies and has a Ph.D. from Stanford University, contributing to his expertise in life sciences and biotechnology.

Work Experience 

  • Senior Associate

    2023 - Current

  • Associate

    2021 - 2023

  • Senior Analyst

    2020 - 2021

Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.

  • Board Member

    2023

Spyglass Pharma provides medicine for ophthalmic diseases.

Raised $109,782,347.00 from RA Capital Management, Vertex Ventures HC, New Enterprise Associates, Samsara BioCapital and Vensana Capital.

  • Board Member

    2021

Respiras high efficiency AOS Dry Powder Inhaler (DPI) technologies deliver dry powder drug products to the lung more effectively.

Raised $5,100,000.00 from Keiretsu Forum Northwest.

  • Board Observer

    2021 - 2023

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Raised $278,000,000.00 from Venrock Healthcare Capital Partners, OrbiMed, Samsara BioCapital, TCG Crossover and RA Capital Management.

  • Board Observer

    2021 - 2023

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Raised $310,000,000.00 from Woodline Partners, Ally Bridge Group, Saturn V Capital, Novo Holdings, Perceptive Advisors, T. Rowe Price, Wellington Management, Third Rock Ventures, Opaleye Management and Samsara BioCapital.

  • Virology Intern

    2012 - 2013

Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on

Articles About Roger

Relevant Websites